Lipella Pharmaceuticals (LIPO) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Lipella Pharmaceuticals Revenue Highlights


Latest Revenue (Y)

$449.62M

Latest Revenue (Q)

$136.43M

Main Segment (Y)

Grant Revenues

Lipella Pharmaceuticals Revenue by Period


Lipella Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$449.62M244050.07%
2022-12-31$184.16K-28.99%
2021-12-31$259.35K-73.03%
2020-12-31$961.68K38.42%
2019-12-31$694.75K-

Lipella Pharmaceuticals generated $449.62M in revenue during NA 2023, up 244050.07% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Lipella Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30$136.43M93422.76%
2024-03-31$145.88K20.72%
2023-12-31$120.84K-99.88%
2023-09-30$104.05M-2.46%
2023-06-30$106.68M90266.63%
2023-03-31$118.05K-21.83%
2022-12-31$151.01K100.00%
2022-09-30-100.00%
2022-06-30--100.00%
2022-03-31$33.15K28.08%
2021-12-31$25.88K100.00%
2021-09-30--100.00%
2021-06-30$148.97K76.30%
2021-03-31$84.50K-

Lipella Pharmaceuticals generated $136.43M in revenue during Q2 2024, up 93422.76% compared to the previous quarter, and up 115572.48% compared to the same period a year ago.

Lipella Pharmaceuticals Revenue Breakdown


Lipella Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22
Grant Revenues$184.16K

Lipella Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 22: Grant Revenues (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 23Mar 23
Grant Revenues$104.05K$118.05K

Lipella Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Grant Revenues (100.00%).

Lipella Pharmaceuticals Revenue Breakdown by Country

Quarterly Revenue by Country

CountryMar 23
Grant Revenues$118.05K

Lipella Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Mar 23: Grant Revenues (100.00%).

Lipella Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
LIPOLipella Pharmaceuticals$449.62M$136.43M
FENCFennec Pharmaceuticals$21.64M$25.26M
ICCCImmuCell$17.47M$7.26M
SNTISenti Biosciences$2.56M-
INBXInhibrx Biosciences$1.80M-
ANEBAnebulo Pharmaceuticals--
ELYMEliem Therapeutics--
ACRVAcrivon Therapeutics--
CELCCelcuity--
MNPRMonopar Therapeutics--
MACKMerrimack Pharmaceuticals--
PTIXProtagenic Therapeutics--
ELVNEnliven Therapeutics--

LIPO Revenue FAQ


Lipella Pharmaceuticals's yearly revenue for 2023 was $449.62M, representing an increase of 244050.07% compared to 2022. The company's yearly revenue for 2022 was $184.16K, representing a decrease of -28.99% compared to 2021. LIPO's yearly revenue for 2021 was $259.35K, representing a decrease of -73.03% compared to 2020.

Lipella Pharmaceuticals's quarterly revenue for Q2 2024 was $136.43M, a 93422.76% increase from the previous quarter (Q1 2024), and a 27.89% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $145.88K, a 20.72% increase from the previous quarter (Q4 2023), and a 23.58% increase year-over-year (Q1 2023). LIPO's quarterly revenue for Q4 2023 was $120.84K, a -99.88% decrease from the previous quarter (Q3 2023), and a -19.98% decrease year-over-year (Q4 2022).

Lipella Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 173265.03%, and for the last 5 years (2019-2023) was 64616.56%.

Lipella Pharmaceuticals's revenue streams in c 22 are Grant Revenues

For the fiscal year ending Dec 22, the largest source of revenue of Lipella Pharmaceuticals was Grant Revenues. This segment made a revenue of $184.16K, representing 100.00% of the company's total revenue.